Machine Intelligence for Human Health

We apply machine learning and novel nucleotide chemistry to the study, diagnosis, and treatment of disease.

Unparalleled Diagnostic Scale.
Better Drugs, Faster.
Unprecedented Research Potential.

cures.

Angstrom Massively Parallel Diagnostic

Population-Scale Molecular Diagnostic.
Unprecedented Throughput.
Unrivaled Sensitivity.
Scale-Enabling Cost.


A Critical Element in the Fight Against COVID-19.
And Beyond.

innovation at
Ångström resolution

population scale ngs diagnostics
Platform for cost-effective, massively-parallel, NGS-based viral diagnostics, including COVID-19
AMPD
Optimizing Research and Therapeutics
Computational optimization of both
in vitro & immunization derived antibodies
E-Mail to Learn More
COVID-19 RESOURCES
Angstrom's response to the COVID-19 pandemic


COVID-19

Founding Team

Carlos Santos, Ph.D.
Carlos Santos, Ph.D.
Chief Executive Officer
Austin, TX
Carlos Santos, Ph.D.
David States, M.D., Ph.D.
Chief Science Officer
Ann Arbor, MI
Carlos Santos, Ph.D.
Forrest Cox
Chief Strategy Officer
San Francisco, CA
Carlos Santos, Ph.D.
Jonathan (JP) Feldmann
COO & CTO
Austin, TX
Carlos Santos, Ph.D.
Josue Moran, Ph.D.
VP, Research & Development
Austin, TX

Interested in Learning More About Angstrom?

We would love to hear from you.

E-Mail us at info@angstrom.bio